Human Atlas
Interactive pharmacy
See what a medicine changes.
Follow a drug through the body. Explore the mechanism, connect effects to anatomy, and test the reasoning behind them.
Follow a medicine from receptor action to tissue response, benefit, adverse effects, and clinical context.
One receptor family. A body full of consequences.
Why can a medicine for bowel spasms also dry the mouth and blur vision?
01—02
A membrane, a receptor, a signal
Building molecular scene…
Muscarinic receptors receive acetylcholine signals. This scene isolates that interaction to explain one part of dicyclomine’s action.
Beyond the highlighted organsFuller safety context & source evidence +
Other reported events include fatigue, malaise, suppressed lactation, allergic skin reactions and hypersensitivity, including angioedema and anaphylactic shock. These are not all represented by discrete organ meshes. Related-drug reports in §6.3 are a separate evidence category.
What was actually observed?
Label-reported controlled trials: over 100 patients with functional bowel / IBS; initial dicyclomine exposure 40 mg four times daily (160 mg/day). These historical rates are not personal probabilities or a dosing recommendation.
| Reported event | Dicyclomine | Placebo |
|---|---|---|
| Dizziness | 40% | 5% |
| Dry mouth | 33% | 5% |
| Blurred vision | 27% | 2% |
| Nausea | 14% | 6% |
| Somnolence | 9% | 1% |
| Asthenia | 7% | 1% |
| Nervousness | 6% | 2% |
The lessons explain selected mechanisms and label-reported effects. They are not comprehensive contraindication checks, dosing tools, diagnoses, or personal treatment recommendations.
Connected label sourcesLoad current public label records +
The explorer is an educational relationship map. Medication specific decisions require current labeling, clinical guidance, and patient specific assessment.